← Back to Search

Digital Care Plans for Genetic Predisposition to Cancer

N/A
Recruiting
Led By Suzanne MacFarland, MD
Research Sponsored by Children's Hospital of Philadelphia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months after receipt of digital care plan
Awards & highlights

Study Summary

This trial will look at using digital care plans and text reminders to help children and teens with inherited cancer risk.

Who is the study for?
This trial is for children and adolescents over the age of 12, along with their parents or legal guardians, who are being followed up at CHOP for a known Cancer Predisposition Syndrome diagnosed within the last three years. Participants must be able to understand and speak English without cognitive impairments that limit their ability to complete study tasks.Check my eligibility
What is being tested?
The trial aims to develop and test digital care plans complemented by text message reminders. These tools are designed for young patients with Cancer Predisposition Syndromes to assess how acceptable, feasible, and effective they are in managing health care needs.See study design
What are the potential side effects?
Since this trial involves digital care plans rather than medication or invasive procedures, traditional physical side effects aren't expected. However, participants may experience stress or anxiety related to following a new care regimen.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months after receipt of digital care plan
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months after receipt of digital care plan for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Knowledge Score of participating family members
Secondary outcome measures
Acceptability of use of digital care plans for CPS for participating family members
Change in cancer-related anxiety
Change in distress after receiving genetic test results
+2 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Intervention: Digital Care Plans with Accompanying Text MessagesExperimental Treatment1 Intervention
Investigators will recruit families and patients diagnosed with a Cancer Predisposition Syndrome within 3 years. Participants will be provided with a digital care plan and optional accompanying text message reminders.

Find a Location

Who is running the clinical trial?

Children's Hospital of PhiladelphiaLead Sponsor
708 Previous Clinical Trials
8,582,864 Total Patients Enrolled
National Institutes of Health (NIH)NIH
2,701 Previous Clinical Trials
7,506,694 Total Patients Enrolled
National Human Genome Research Institute (NHGRI)NIH
263 Previous Clinical Trials
283,976 Total Patients Enrolled

Media Library

Digital Care Plans Clinical Trial Eligibility Overview. Trial Name: NCT05736497 — N/A
Genetic Predisposition Research Study Groups: Intervention: Digital Care Plans with Accompanying Text Messages
Genetic Predisposition Clinical Trial 2023: Digital Care Plans Highlights & Side Effects. Trial Name: NCT05736497 — N/A
Digital Care Plans 2023 Treatment Timeline for Medical Study. Trial Name: NCT05736497 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the trial actively enrolling participants?

"Clinicaltrials.gov's records indicate that this trial is not currently seeking patients, having been first published on February 1st 2023 and last updated on the 8th of February. However, there are 38 other studies actively recruiting participants at present."

Answered by AI
~43 spots leftby Aug 2024